HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

PCA 10

Also Known As:

1-acetyl-2-(3-pyrrolidino-1-propynyl)piperidine; PCA-10; PCA 10 (plastic)

Networked: 14 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrrolidines: 115
    - Pyrrolidinones: 162
      - PCA 10: 14

Experts

1.	Adefegha, Stephen A: 2 articles (07/2019 - 01/2015)
2.	Dao, Thuy Nguyen Thi: 1 article (01/2022)
3.	Jang, Yoon Ok: 1 article (01/2022)
4.	Kim, Choung-Soo: 1 article (01/2022)
5.	Kim, Hyun Soo: 1 article (01/2022)
6.	Kim, Myoung Gyu: 1 article (01/2022)
7.	Kim, Yunlim: 1 article (01/2022)
8.	Koo, Bonhan: 1 article (01/2022)
9.	Lee, Hyo Joo: 1 article (01/2022)
10.	Liu, Huifang: 1 article (01/2022)

Related Diseases

1.	Neoplasms (Cancer) 09/01/2015 - "However AZ biopsies increased detection rate for PCa (10% of the cases), the majority of AZ PCa with histological findings predictive of clinically significant cancer were found at repeat biopsy (about 70% of the cases)." 11/01/2006 - "The prevalence of the pancreatic tumors in the PD patients was: PCA, 10%; IPMN, 5.1%; other pancreatic tumors, 2.5%. " 04/25/2002 - "The authors reviewed 22 fine-needle aspirates (FNAs) from histologically proven papillary neoplasms: papillary carcinoma (PCA; 10 aspirates) and intraductal papilloma (IDP; 12 aspirates). "
2.	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/01/2013 - "Serum samples were collected to measure the miR-141 level in 56 patients, including six with benign prostatic hyperplasia (BPH), 20 with localized PCa and 30 with bone-metastatic PCa (10 with hormone-naive PCa, 10 with hormone-sensitive PCa and 10 with hormone-refractory PCa). " 01/01/2022 - "Finally, the chimeric nanocomposites are used to assess urinary exosomal miRNAs from urine specimens from 20 prostate cancer (PCa), 10 benign prostatic hyperplasia (BPH), patients and 10 healthy controls. "
3.	Body Weight (Weight, Body) 07/08/2019 - "A single dose of DOX at 20 mg/kg was administered intraperitoneally (i.p.) to animals in Group 2. Groups 3 and 4 were pretreated with PCA for 5 days (doses of 10 and 20 mg/kg body weight, respectively) after which DOX was injected (PCA-10 + DOX and PCA-20 + DOX). " 01/01/2015 - "Thirty six adult male rats weighing about 150-160 g were acclimatized for 2 weeks and subsequently divided into six groups: Group 1 rats received normal saline (control group), group 2 rats were administered 5 mg Cd/kg body weight in form of solution orally (induced group), groups 3 and 4 received cadmium solution and different doses of PCA (10 and 20 mg/kg body weight) respectively, while groups 5 and 6 were the normal rats administered different doses of PCA (10 and 20 mg/kg) respectively in an experiment that lasted for twenty one days. "
4.	Atrophy 11/10/2009 - "Voxel-based morphometry (VBM) was used to assess atrophy in 14 PCA, 10 LPA, and 16 EO-AD patients compared to 65 healthy controls. " 04/01/2019 - "Three groups were studied: 11 people with posterior cortical atrophy (PCA), 10 with typical Alzheimer's disease (tAD) and 13 controls. "
5.	Lung Injury 10/01/2021 - "In this investigation we studied the potential protective role of pure PCA (10, 20 and 30 mg/kg) on LPS-mediated septic lung injury in mice through examining oxidative challenge, inflammatory response, apoptotic events and histopathological changes in addition to evaluating the levels and mRNA expression of heat shock protein 70, C/EBP homologous protein and high mobility group box1 in the lung tissue. "

Related Drugs and Biologics

1.	Solutions
2.	Transcription Factor CHOP
3.	MicroRNAs (MicroRNA)
4.	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)
5.	Selegiline (E250)
6.	Messenger RNA (mRNA)
7.	Inosine Diphosphate (IDP)
8.	Hormones (Hormone)
9.	Cadmium
10.	Saline Solution